Xuejun Chen

14PUBLICATIONS
141CO-AUTHORS
Innate immunityComputational linguisticsMedical devicesMedical virologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection.

Joana Dias, Giulia Fabozzi, Slim Fourati

|May 16, 2024
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.

Christopher A Cottrell, Xiaozhen Hu, Jeong Hyun Lee

|Jan 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge.

Amarendra Pegu, Sarah E Lovelace, Megan E DeMouth

|Jan 04, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability.

Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan

|Apr 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.

Joseph P Casazza, Evan M Cale, Sandeep Narpala

|Dec 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.

Peng Zhang, Elisabeth Narayanan, Qingbo Liu

Pageof 3

Frequent Collaborators

5 joint publications

Amarendra Pegu

5 joint publications

Peter D Kwong

4 joint publications

John R Mascola

4 joint publications

Nicole Doria-Rose